Kirchhofer D, Tschopp T B, Steiner B, Baumgartner H R
F. Hoffmann-La Roche Ltd, Pharma Division, Preclinical Research, Basel, Switzerland.
Blood. 1995 Nov 15;86(10):3815-22.
Activated platelets provide assembly sites for coagulation enzyme complexes and in this way can mediate coagulation during hemostasis and thrombosis. In this study, we examined the procoagulant activity of platelets adhering directly to fibrillar collagen, a main thrombogenic constituent of subendothelium. For this purpose, we used a human ex-vivo thrombosis model in which collagen-coated coverslips were exposed to flowing nonanticoagulated blood (shear rate, 65/s) for 5.5 minutes, which led to the deposition of adherent platelets, platelet thrombi, and fibrin. To examine the procoagulant activity of adherent platelets only, a selective antagonist of the platelet GPIIb-IIIa complex, Ro 44-9883, was infused via a mixing device, resulting in a complete abrogation of platelet thrombus formation but leaving the collagen-adherent platelet layer intact. This platelet layer generated increased postchamber fibrinopeptide A (FPA) levels (203 +/- 33 ng/mL) as compared with control experiments without infusion of inhibitor (95 +/- 13 ng/mL). Concomitantly, fibrin deposition measured by morphometric analysis of cross-sections was also increased, as was the platelet adhesion to collagen. An immunochemical staining of fibrin fibers further showed that the adherent platelets formed the nuclei for fibrin fiber formation. This increase in fibrin deposition was mediated by the intrinsic factor X (F.X) activation complex on adherent single platelets, because almost complete inhibition of FPA generation (9 ng/mL) and fibrin deposition (0.4% +/- 0.2% coverage) was achieved upon coinfusion of the GP IIb-IIIa antagonist and active site-inhibited F.IXa. The large platelet thrombi that were deposited in control experiments contained no significant amounts of immunodetectable fibrin except at the thrombus base, where adherent platelets anchored the thrombi to the collagen surface. These results suggest that the collagen-adherent platelets are important promoters of coagulation during the initial phase of thrombogenesis by providing assembly sites for the F.X activation complex.
活化的血小板为凝血酶复合物提供组装位点,从而在止血和血栓形成过程中介导凝血。在本研究中,我们检测了直接黏附于纤维状胶原蛋白(内皮细胞下层主要的血栓形成成分)的血小板的促凝活性。为此,我们使用了一种人体体外血栓形成模型,将包被有胶原蛋白的盖玻片暴露于流动的非抗凝血液(剪切速率为65/s)中5.5分钟,这导致了黏附血小板、血小板血栓和纤维蛋白的沉积。为了仅检测黏附血小板的促凝活性,通过混合装置注入血小板糖蛋白IIb-IIIa复合物的选择性拮抗剂Ro 44-9883,导致血小板血栓形成完全消除,但胶原黏附的血小板层保持完整。与未注入抑制剂的对照实验相比(95±13 ng/mL),该血小板层使腔后纤维蛋白肽A(FPA)水平升高(203±33 ng/mL)。同时,通过横截面形态计量分析测量的纤维蛋白沉积也增加,血小板对胶原的黏附也增加。纤维蛋白纤维的免疫化学染色进一步表明,黏附的血小板形成了纤维蛋白纤维形成的核心。这种纤维蛋白沉积的增加是由黏附的单个血小板上的内源性因子X(F.X)激活复合物介导的,因为在同时注入糖蛋白IIb-IIIa拮抗剂和活性位点抑制的F.IXa后,FPA生成(9 ng/mL)和纤维蛋白沉积(0.4%±0.2%覆盖)几乎完全受到抑制。在对照实验中沉积的大血小板血栓除了在血栓基部外,不含有大量可免疫检测到的纤维蛋白,在血栓基部,黏附的血小板将血栓锚定在胶原表面。这些结果表明,胶原黏附的血小板通过为F.X激活复合物提供组装位点,在血栓形成的初始阶段是凝血的重要促进者。